Addex Therapeutics, a clinical-stage biopharmaceutical company, has reported its Q1 2024 financial results and provided a corporate update. The company…
23andMe Holding Co. (Nasdaq: ME) has announced that it will be reporting its financial results for the fourth quarter and…
MacroGenics, Inc. (Nasdaq: MGNX), a leading biopharmaceutical company specializing in antibody-based therapeutics for cancer treatment, is set to release its…
